Loading…

Discovery of Orally Active, Potent, and Selective Benzotriazole-Based PTP1B Inhibitors

A two‐hand grasp on one enzyme: A novel series of dual‐site benzotriazole derivatives are reported as potent PTP1B inhibitors. Some of the test compounds exhibit good selectivity for PTP1B over various other PTPs, including TCPTP (in vitro), and the lead compound 10 h shows excellent antidiabetic ac...

Full description

Saved in:
Bibliographic Details
Published in:ChemMedChem 2011-06, Vol.6 (6), p.1011-1016
Main Authors: Patel, Dipam, Jain, Mukul, Shah, Shailesh R., Bahekar, Rajesh, Jadav, Pradip, Darji, Brijesh, Siriki, Yernaidu, Bandyopadhyay, Debdutta, Joharapurkar, Amit, Kshirsagar, Samadhan, Patel, Harilal, Shaikh, Mubeen, Sairam, Kalapatapu V. V. M., Patel, Pankaj
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4487-1249ee6516ab2880c6ef9ddc993812aeec09e305f767ef0a76f79ce993e5c2ed3
cites cdi_FETCH-LOGICAL-c4487-1249ee6516ab2880c6ef9ddc993812aeec09e305f767ef0a76f79ce993e5c2ed3
container_end_page 1016
container_issue 6
container_start_page 1011
container_title ChemMedChem
container_volume 6
creator Patel, Dipam
Jain, Mukul
Shah, Shailesh R.
Bahekar, Rajesh
Jadav, Pradip
Darji, Brijesh
Siriki, Yernaidu
Bandyopadhyay, Debdutta
Joharapurkar, Amit
Kshirsagar, Samadhan
Patel, Harilal
Shaikh, Mubeen
Sairam, Kalapatapu V. V. M.
Patel, Pankaj
description A two‐hand grasp on one enzyme: A novel series of dual‐site benzotriazole derivatives are reported as potent PTP1B inhibitors. Some of the test compounds exhibit good selectivity for PTP1B over various other PTPs, including TCPTP (in vitro), and the lead compound 10 h shows excellent antidiabetic activity (in vivo).
doi_str_mv 10.1002/cmdc.201100077
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_868997003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>868997003</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4487-1249ee6516ab2880c6ef9ddc993812aeec09e305f767ef0a76f79ce993e5c2ed3</originalsourceid><addsrcrecordid>eNqFkElPwzAQhS0EgrJcOSLfuJBiJ42XY5tCW6mUSqw3y3UmIpDGxU6B9NcTKFTcOM2M53tP44fQMSVtSkh4buapaYeENgPhfAu1qGAk4FTw7U3P5R7a9_6ZkE5HULGL9kIaExZy0UL3_dwb-wauxjbD104XRY27psrf4AxPbQVldYZ1meIbKOD7GfegXNnK5XplCwh62kOKp7dT2sOj8imf5ZV1_hDtZLrwcPRTD9Dd5cVtMgzG14NR0h0HpjmFBzTsSAAWU6ZnoRDEMMhkmhopI0FDDWCIhIjEGWccMqI5y7g00KwhNiGk0QE6XfsunH1dgq_UvPkPFIUuwS69EkxIyQmJGrK9Jo2z3jvI1MLlc-1qRYn6ilJ9Rak2UTaCkx_r5WwO6Qb_za4B5Bp4zwuo_7FTyVU_-WserLW5r-Bjo9XuRTEe8Vg9TAYqSQQbRv1HNYk-ARdYjsA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>868997003</pqid></control><display><type>article</type><title>Discovery of Orally Active, Potent, and Selective Benzotriazole-Based PTP1B Inhibitors</title><source>Wiley</source><creator>Patel, Dipam ; Jain, Mukul ; Shah, Shailesh R. ; Bahekar, Rajesh ; Jadav, Pradip ; Darji, Brijesh ; Siriki, Yernaidu ; Bandyopadhyay, Debdutta ; Joharapurkar, Amit ; Kshirsagar, Samadhan ; Patel, Harilal ; Shaikh, Mubeen ; Sairam, Kalapatapu V. V. M. ; Patel, Pankaj</creator><creatorcontrib>Patel, Dipam ; Jain, Mukul ; Shah, Shailesh R. ; Bahekar, Rajesh ; Jadav, Pradip ; Darji, Brijesh ; Siriki, Yernaidu ; Bandyopadhyay, Debdutta ; Joharapurkar, Amit ; Kshirsagar, Samadhan ; Patel, Harilal ; Shaikh, Mubeen ; Sairam, Kalapatapu V. V. M. ; Patel, Pankaj</creatorcontrib><description>A two‐hand grasp on one enzyme: A novel series of dual‐site benzotriazole derivatives are reported as potent PTP1B inhibitors. Some of the test compounds exhibit good selectivity for PTP1B over various other PTPs, including TCPTP (in vitro), and the lead compound 10 h shows excellent antidiabetic activity (in vivo).</description><identifier>ISSN: 1860-7179</identifier><identifier>EISSN: 1860-7187</identifier><identifier>DOI: 10.1002/cmdc.201100077</identifier><identifier>PMID: 21506278</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Administration, Oral ; Animals ; benzotriazoles ; Diabetes Mellitus - drug therapy ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacokinetics ; Enzyme Inhibitors - pharmacology ; Enzyme Inhibitors - therapeutic use ; Humans ; Hypoglycemic Agents - chemistry ; Hypoglycemic Agents - pharmacokinetics ; Hypoglycemic Agents - pharmacology ; Hypoglycemic Agents - therapeutic use ; inhibitors ; Male ; metabolic disorders ; Mice ; Mice, Inbred C57BL ; Models, Molecular ; Protein Binding ; Protein Tyrosine Phosphatase, Non-Receptor Type 1 - antagonists &amp; inhibitors ; Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism ; PTP1B ; Rats ; Rats, Wistar ; Structure-Activity Relationship ; TCPTP ; Triazoles - chemistry ; Triazoles - pharmacokinetics ; Triazoles - pharmacology ; Triazoles - therapeutic use</subject><ispartof>ChemMedChem, 2011-06, Vol.6 (6), p.1011-1016</ispartof><rights>Copyright © 2011 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4487-1249ee6516ab2880c6ef9ddc993812aeec09e305f767ef0a76f79ce993e5c2ed3</citedby><cites>FETCH-LOGICAL-c4487-1249ee6516ab2880c6ef9ddc993812aeec09e305f767ef0a76f79ce993e5c2ed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21506278$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Patel, Dipam</creatorcontrib><creatorcontrib>Jain, Mukul</creatorcontrib><creatorcontrib>Shah, Shailesh R.</creatorcontrib><creatorcontrib>Bahekar, Rajesh</creatorcontrib><creatorcontrib>Jadav, Pradip</creatorcontrib><creatorcontrib>Darji, Brijesh</creatorcontrib><creatorcontrib>Siriki, Yernaidu</creatorcontrib><creatorcontrib>Bandyopadhyay, Debdutta</creatorcontrib><creatorcontrib>Joharapurkar, Amit</creatorcontrib><creatorcontrib>Kshirsagar, Samadhan</creatorcontrib><creatorcontrib>Patel, Harilal</creatorcontrib><creatorcontrib>Shaikh, Mubeen</creatorcontrib><creatorcontrib>Sairam, Kalapatapu V. V. M.</creatorcontrib><creatorcontrib>Patel, Pankaj</creatorcontrib><title>Discovery of Orally Active, Potent, and Selective Benzotriazole-Based PTP1B Inhibitors</title><title>ChemMedChem</title><addtitle>ChemMedChem</addtitle><description>A two‐hand grasp on one enzyme: A novel series of dual‐site benzotriazole derivatives are reported as potent PTP1B inhibitors. Some of the test compounds exhibit good selectivity for PTP1B over various other PTPs, including TCPTP (in vitro), and the lead compound 10 h shows excellent antidiabetic activity (in vivo).</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>benzotriazoles</subject><subject>Diabetes Mellitus - drug therapy</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacokinetics</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Humans</subject><subject>Hypoglycemic Agents - chemistry</subject><subject>Hypoglycemic Agents - pharmacokinetics</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>inhibitors</subject><subject>Male</subject><subject>metabolic disorders</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Models, Molecular</subject><subject>Protein Binding</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 1 - antagonists &amp; inhibitors</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism</subject><subject>PTP1B</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Structure-Activity Relationship</subject><subject>TCPTP</subject><subject>Triazoles - chemistry</subject><subject>Triazoles - pharmacokinetics</subject><subject>Triazoles - pharmacology</subject><subject>Triazoles - therapeutic use</subject><issn>1860-7179</issn><issn>1860-7187</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkElPwzAQhS0EgrJcOSLfuJBiJ42XY5tCW6mUSqw3y3UmIpDGxU6B9NcTKFTcOM2M53tP44fQMSVtSkh4buapaYeENgPhfAu1qGAk4FTw7U3P5R7a9_6ZkE5HULGL9kIaExZy0UL3_dwb-wauxjbD104XRY27psrf4AxPbQVldYZ1meIbKOD7GfegXNnK5XplCwh62kOKp7dT2sOj8imf5ZV1_hDtZLrwcPRTD9Dd5cVtMgzG14NR0h0HpjmFBzTsSAAWU6ZnoRDEMMhkmhopI0FDDWCIhIjEGWccMqI5y7g00KwhNiGk0QE6XfsunH1dgq_UvPkPFIUuwS69EkxIyQmJGrK9Jo2z3jvI1MLlc-1qRYn6ilJ9Rak2UTaCkx_r5WwO6Qb_za4B5Bp4zwuo_7FTyVU_-WserLW5r-Bjo9XuRTEe8Vg9TAYqSQQbRv1HNYk-ARdYjsA</recordid><startdate>20110606</startdate><enddate>20110606</enddate><creator>Patel, Dipam</creator><creator>Jain, Mukul</creator><creator>Shah, Shailesh R.</creator><creator>Bahekar, Rajesh</creator><creator>Jadav, Pradip</creator><creator>Darji, Brijesh</creator><creator>Siriki, Yernaidu</creator><creator>Bandyopadhyay, Debdutta</creator><creator>Joharapurkar, Amit</creator><creator>Kshirsagar, Samadhan</creator><creator>Patel, Harilal</creator><creator>Shaikh, Mubeen</creator><creator>Sairam, Kalapatapu V. V. M.</creator><creator>Patel, Pankaj</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110606</creationdate><title>Discovery of Orally Active, Potent, and Selective Benzotriazole-Based PTP1B Inhibitors</title><author>Patel, Dipam ; Jain, Mukul ; Shah, Shailesh R. ; Bahekar, Rajesh ; Jadav, Pradip ; Darji, Brijesh ; Siriki, Yernaidu ; Bandyopadhyay, Debdutta ; Joharapurkar, Amit ; Kshirsagar, Samadhan ; Patel, Harilal ; Shaikh, Mubeen ; Sairam, Kalapatapu V. V. M. ; Patel, Pankaj</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4487-1249ee6516ab2880c6ef9ddc993812aeec09e305f767ef0a76f79ce993e5c2ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>benzotriazoles</topic><topic>Diabetes Mellitus - drug therapy</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacokinetics</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Humans</topic><topic>Hypoglycemic Agents - chemistry</topic><topic>Hypoglycemic Agents - pharmacokinetics</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>inhibitors</topic><topic>Male</topic><topic>metabolic disorders</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Models, Molecular</topic><topic>Protein Binding</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 1 - antagonists &amp; inhibitors</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism</topic><topic>PTP1B</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Structure-Activity Relationship</topic><topic>TCPTP</topic><topic>Triazoles - chemistry</topic><topic>Triazoles - pharmacokinetics</topic><topic>Triazoles - pharmacology</topic><topic>Triazoles - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patel, Dipam</creatorcontrib><creatorcontrib>Jain, Mukul</creatorcontrib><creatorcontrib>Shah, Shailesh R.</creatorcontrib><creatorcontrib>Bahekar, Rajesh</creatorcontrib><creatorcontrib>Jadav, Pradip</creatorcontrib><creatorcontrib>Darji, Brijesh</creatorcontrib><creatorcontrib>Siriki, Yernaidu</creatorcontrib><creatorcontrib>Bandyopadhyay, Debdutta</creatorcontrib><creatorcontrib>Joharapurkar, Amit</creatorcontrib><creatorcontrib>Kshirsagar, Samadhan</creatorcontrib><creatorcontrib>Patel, Harilal</creatorcontrib><creatorcontrib>Shaikh, Mubeen</creatorcontrib><creatorcontrib>Sairam, Kalapatapu V. V. M.</creatorcontrib><creatorcontrib>Patel, Pankaj</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ChemMedChem</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patel, Dipam</au><au>Jain, Mukul</au><au>Shah, Shailesh R.</au><au>Bahekar, Rajesh</au><au>Jadav, Pradip</au><au>Darji, Brijesh</au><au>Siriki, Yernaidu</au><au>Bandyopadhyay, Debdutta</au><au>Joharapurkar, Amit</au><au>Kshirsagar, Samadhan</au><au>Patel, Harilal</au><au>Shaikh, Mubeen</au><au>Sairam, Kalapatapu V. V. M.</au><au>Patel, Pankaj</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovery of Orally Active, Potent, and Selective Benzotriazole-Based PTP1B Inhibitors</atitle><jtitle>ChemMedChem</jtitle><addtitle>ChemMedChem</addtitle><date>2011-06-06</date><risdate>2011</risdate><volume>6</volume><issue>6</issue><spage>1011</spage><epage>1016</epage><pages>1011-1016</pages><issn>1860-7179</issn><eissn>1860-7187</eissn><abstract>A two‐hand grasp on one enzyme: A novel series of dual‐site benzotriazole derivatives are reported as potent PTP1B inhibitors. Some of the test compounds exhibit good selectivity for PTP1B over various other PTPs, including TCPTP (in vitro), and the lead compound 10 h shows excellent antidiabetic activity (in vivo).</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>21506278</pmid><doi>10.1002/cmdc.201100077</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1860-7179
ispartof ChemMedChem, 2011-06, Vol.6 (6), p.1011-1016
issn 1860-7179
1860-7187
language eng
recordid cdi_proquest_miscellaneous_868997003
source Wiley
subjects Administration, Oral
Animals
benzotriazoles
Diabetes Mellitus - drug therapy
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacokinetics
Enzyme Inhibitors - pharmacology
Enzyme Inhibitors - therapeutic use
Humans
Hypoglycemic Agents - chemistry
Hypoglycemic Agents - pharmacokinetics
Hypoglycemic Agents - pharmacology
Hypoglycemic Agents - therapeutic use
inhibitors
Male
metabolic disorders
Mice
Mice, Inbred C57BL
Models, Molecular
Protein Binding
Protein Tyrosine Phosphatase, Non-Receptor Type 1 - antagonists & inhibitors
Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism
PTP1B
Rats
Rats, Wistar
Structure-Activity Relationship
TCPTP
Triazoles - chemistry
Triazoles - pharmacokinetics
Triazoles - pharmacology
Triazoles - therapeutic use
title Discovery of Orally Active, Potent, and Selective Benzotriazole-Based PTP1B Inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T01%3A31%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovery%20of%20Orally%20Active,%20Potent,%20and%20Selective%20Benzotriazole-Based%20PTP1B%20Inhibitors&rft.jtitle=ChemMedChem&rft.au=Patel,%20Dipam&rft.date=2011-06-06&rft.volume=6&rft.issue=6&rft.spage=1011&rft.epage=1016&rft.pages=1011-1016&rft.issn=1860-7179&rft.eissn=1860-7187&rft_id=info:doi/10.1002/cmdc.201100077&rft_dat=%3Cproquest_cross%3E868997003%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4487-1249ee6516ab2880c6ef9ddc993812aeec09e305f767ef0a76f79ce993e5c2ed3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=868997003&rft_id=info:pmid/21506278&rfr_iscdi=true